Skip to main contentSkip to navigation
Sirius Investors
Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

RAPH
OTCHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for RAPH. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
27.37M
-19.65% over period
CAGR: -5.32%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
27.36M
-19.32% over period
CAGR: -5.22%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Mar 31, 2026

EV/EBITDA

Distorted

-126.83x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

-11.00K

EV is -0.0% vs equity value

Capital Structure Signal

Net Cash Profile

EV premium trend: +0.4 pp vs earliest data

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: -0.16x

Share count change in dataset: +26.27%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 202527.37M27.36M$1.4019.55M
Dec 31, 20244.86M4.88M$0.2618.67M
Dec 31, 202316.72M16.49M$1.0016.72M
Dec 31, 2022
Dec 31, 2021

Enterprise Value Analysis

Price Change (Dec 2024 to Dec 2025)

The stock price has increased from Dec 2024 to Dec 2025.
+438.46%

Recent Volatility

The stock price has been relatively volatile over the last 5 periods, indicating a higher risk profile.
2.10

Risk-Adjusted Return

The stock's returns compensate somewhat for its risk, suggesting a moderate investment opportunity.
0.37

Market Cap Change (Dec 2024 to Dec 2025)

The company's market capitalization has increased from Dec 2024 to Dec 2025.
+463.77%

Enterprise Value Change (Dec 2024 to Dec 2025)

The company's enterprise value has increased from Dec 2024 to Dec 2025, suggesting growth in the company's total economic value.
+461.00%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (5 periods), accounting for compounding effects.
-5.32%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (5 periods), accounting for compounding effects.
-5.22%